vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Fidelity National Financial, Inc. (FNF). Click either name above to swap in a different company.
Fidelity National Financial, Inc. is the larger business by last-quarter revenue ($544.0M vs $284.0M, roughly 1.9× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs -21.5%, a 117.8% gap on every dollar of revenue. On growth, Fidelity National Financial, Inc. posted the faster year-over-year revenue change (10.3% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 13.7%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.
ACAD vs FNF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $544.0M |
| Net Profit | $273.6M | $-117.0M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 82.9% |
| Net Margin | 96.3% | -21.5% |
| Revenue YoY | 9.4% | 10.3% |
| Net Profit YoY | 90.3% | -126.0% |
| EPS (diluted) | $1.61 | $-0.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $544.0M | ||
| Q3 25 | $278.6M | $553.0M | ||
| Q2 25 | $264.6M | $547.0M | ||
| Q1 25 | $244.3M | $455.0M | ||
| Q4 24 | $259.6M | $493.0M | ||
| Q3 24 | $250.4M | $506.0M | ||
| Q2 24 | $242.0M | $504.0M | ||
| Q1 24 | $205.8M | $421.0M |
| Q4 25 | $273.6M | $-117.0M | ||
| Q3 25 | $71.8M | $358.0M | ||
| Q2 25 | $26.7M | $278.0M | ||
| Q1 25 | $19.0M | $83.0M | ||
| Q4 24 | $143.7M | $450.0M | ||
| Q3 24 | $32.8M | $266.0M | ||
| Q2 24 | $33.4M | $306.0M | ||
| Q1 24 | $16.6M | $248.0M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | 82.9% | ||
| Q3 25 | 12.8% | 81.9% | ||
| Q2 25 | 12.2% | 69.8% | ||
| Q1 25 | 7.9% | 24.4% | ||
| Q4 24 | 59.1% | — | ||
| Q3 24 | 12.6% | 61.9% | ||
| Q2 24 | 12.6% | 90.9% | ||
| Q1 24 | 7.4% | 78.6% |
| Q4 25 | 96.3% | -21.5% | ||
| Q3 25 | 25.8% | 64.7% | ||
| Q2 25 | 10.1% | 50.8% | ||
| Q1 25 | 7.8% | 18.2% | ||
| Q4 24 | 55.4% | 91.3% | ||
| Q3 24 | 13.1% | 52.6% | ||
| Q2 24 | 13.8% | 60.7% | ||
| Q1 24 | 8.0% | 58.9% |
| Q4 25 | $1.61 | $-0.44 | ||
| Q3 25 | $0.42 | $1.33 | ||
| Q2 25 | $0.16 | $1.02 | ||
| Q1 25 | $0.11 | $0.30 | ||
| Q4 24 | $0.86 | $1.65 | ||
| Q3 24 | $0.20 | $0.97 | ||
| Q2 24 | $0.20 | $1.12 | ||
| Q1 24 | $0.10 | $0.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $2.6B |
| Total DebtLower is stronger | — | $4.4B |
| Stockholders' EquityBook value | $1.2B | $7.4B |
| Total Assets | $1.6B | $109.0B |
| Debt / EquityLower = less leverage | — | 0.59× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $2.6B | ||
| Q3 25 | $258.0M | $3.5B | ||
| Q2 25 | $253.6M | $3.3B | ||
| Q1 25 | $217.7M | $4.5B | ||
| Q4 24 | $319.6M | $3.5B | ||
| Q3 24 | $155.1M | $5.0B | ||
| Q2 24 | $177.1M | $4.9B | ||
| Q1 24 | $204.7M | $3.5B |
| Q4 25 | — | $4.4B | ||
| Q3 25 | — | $4.4B | ||
| Q2 25 | — | $4.4B | ||
| Q1 25 | — | $4.4B | ||
| Q4 24 | — | $4.3B | ||
| Q3 24 | — | $4.2B | ||
| Q2 24 | — | $4.2B | ||
| Q1 24 | — | $3.9B |
| Q4 25 | $1.2B | $7.4B | ||
| Q3 25 | $917.3M | $8.4B | ||
| Q2 25 | $822.4M | $7.9B | ||
| Q1 25 | $765.2M | $7.9B | ||
| Q4 24 | $732.8M | $7.8B | ||
| Q3 24 | $577.2M | $8.1B | ||
| Q2 24 | $516.7M | $7.3B | ||
| Q1 24 | $464.0M | $7.1B |
| Q4 25 | $1.6B | $109.0B | ||
| Q3 25 | $1.3B | $106.6B | ||
| Q2 25 | $1.2B | $102.3B | ||
| Q1 25 | $1.1B | $98.2B | ||
| Q4 24 | $1.2B | $95.4B | ||
| Q3 24 | $976.9M | $94.7B | ||
| Q2 24 | $914.1M | $88.8B | ||
| Q1 24 | $855.1M | $84.5B |
| Q4 25 | — | 0.59× | ||
| Q3 25 | — | 0.53× | ||
| Q2 25 | — | 0.56× | ||
| Q1 25 | — | 0.56× | ||
| Q4 24 | — | 0.56× | ||
| Q3 24 | — | 0.52× | ||
| Q2 24 | — | 0.58× | ||
| Q1 24 | — | 0.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $1.5B |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $1.5B | ||
| Q3 25 | $74.3M | $1.3B | ||
| Q2 25 | $64.0M | $1.9B | ||
| Q1 25 | $20.3M | $1.1B | ||
| Q4 24 | $40.4M | $1.5B | ||
| Q3 24 | $63.2M | $2.4B | ||
| Q2 24 | $25.0M | $1.4B | ||
| Q1 24 | $29.1M | $1.6B |
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $63.2M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | 3.66× | ||
| Q2 25 | 2.40× | 6.82× | ||
| Q1 25 | 1.07× | 13.43× | ||
| Q4 24 | 0.28× | 3.32× | ||
| Q3 24 | 1.93× | 8.89× | ||
| Q2 24 | 0.75× | 4.45× | ||
| Q1 24 | 1.76× | 6.42× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
FNF
| Escrow Fees | $241.0M | 44% |
| Other Title Related Fees And Income | $182.0M | 33% |
| Service Link Excluding Title Premiums Escrow Fees And Subservicing Fees | $87.0M | 16% |
| Insurance Contracts Home Warranty | $31.0M | 6% |
